Document is current

Any future updates will be listed below

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic

Crossref DOI link: https://doi.org/10.1136/rmdopen-2017-000473

Published Online: 2017-07-13

Published Print: 2017-07

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark